Thermo Fisher Scientific Expands Pharma Division in Greenville, North Carolina
03/20/2019
According to company officials the expansion will provide additional capacity for sterile liquid and lyophilized product development and commercial manufacturing.
Included in the site expansion projects are Monza and Ferentino, Italy, and Greenville, North Carolina. In response to customer requests, each of the sites will be equipped with aseptic filling lines and isolator technology. Construction is expected to be completed within the next 24 months.
"These investments will help expand our global sterile manufacturing network and meet the increasing demand from customers that rely on our biologics development and manufacturing expertise," said Michel Lagarde, President of pharma services for Thermo Fisher Scientific.
"We continue to invest to expand our capabilities and help our customers deliver the highest quality medicines to the patients who need them,” Lagarde added.
Most Read
-
-
34th Annual Corporate Survey & the 16th Annual Consultants Survey
Q1 2020
-
Why are Foreign Trade Zones Making a Comeback?
Q3 2020
-
Infrastructure Investment as an Economic Stimulus Tool
Q3 2020
-
2020 Gold & Silver Shovel Awards Recognize State and Local Economic Development Efforts
Q2 2020
-
How are Uncertain Times Altering Company Location Strategies?
Q3 2020
-
The Evolution of Facility Design
Q1 2020